Hepatic and Cardiovascular Consequences of Familial Hypobetalipoproteinemia

Nonalcoholic Fatty Liver Disease

Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228 · see citing works

Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes

Cannon, C. P., Braunwald, E., McCabe, C. H., Rader, D. J., Rouleau, J. L., Belder, R., Joyal, S. V., Hill, K. A., Pfeffer, M. A., & Skene, A. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040583 · Cited by 4,938 · see citing works

Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients

Laurent, S., Boutouyrie, P., Asmar, R., Gautier, I., Laloux, B., Guize, L., Ducimetiere, P., & Benetos, A. (2001) · Hypertension · doi:10.1161/01.hyp.37.5.1236 · Cited by 3,856 · see citing works

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Sever, P., Dahlöf, B., Poulter, N. R., Wedel, H., Beevers, G., Caulfield, M. J., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12948-0 · Cited by 3,757 · see citing works

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345 · see citing works

Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis

Nissen, S. E., Tuzcu, E. M., Schoenhagen, P., Brown, B. G., Ganz, P., Vogel, R. A., Crowe, T., Howard, G., Cooper, C. J., Brodie, B. R., et al. (2004) · JAMA · doi:10.1001/jama.291.9.1071 · Cited by 2,358 · see citing works

Impact of Aortic Stiffness on Survival in End-Stage Renal Disease

Blacher, J., Guerin, A. P., Pannier, B., Marchais, S. J., Safar, M. E., & London, G. M. (1999) · Circulation · doi:10.1161/01.cir.99.18.2434 · Cited by 2,138 · see citing works

Molecular mediators of hepatic steatosis and liver injury

Browning, J. D., & Horton, J. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422422 · Cited by 1,772 · see citing works

Aortic Stiffness Is an Independent Predictor of Primary Coronary Events in Hypertensive Patients

Boutouyrie, P., Tropeano, A., Asmar, R. G., Gautier, I., Bénétos, A., Lacolley, P. J., & Laurent, S. (2002) · Hypertension · doi:10.1161/hy0102.099031 · Cited by 1,745 · see citing works

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis

Angulo, P., Keach, J. C., Batts, K., & Lindor, K. (1999) · Hepatology · doi:10.1002/hep.510300604 · Cited by 1,708 · see citing works

Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study

Assmann, G., Cullen, P., & Schulte, H. (2002) · Circulation · doi:10.1161/hc0302.102575 · Cited by 1,541 · see citing works

Changes in Arterial Stiffness and Wave Reflection With Advancing Age in Healthy Men and Women

Mitchell, G. F., Parise, H., Benjamin, E. J., Larson, M. G., Keyes, M. J., Vita, J. A., Vasan, R. S., & Levy, D. A. (2004) · Hypertension · doi:10.1161/01.hyp.0000128420.01881.aa · Cited by 1,507 · see citing works

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years.

Powell, E. E., Cooksley, G. W. E., Hanson, R., Searle, J., Halliday, J. W., & Powell, L. W. (1990) · Hepatology · doi:10.1002/hep.1840110114 · Cited by 1,473 · see citing works

Nonalcoholic steatohepatitis: An expanded clinical entity

Bacon, B. R., Farahvash, M. J., Janney, C. G., & Neuschwander‐Tetri, B. A. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90235-6 · Cited by 1,137 · see citing works

Aortic Stiffness Is an Independent Predictor of Fatal Stroke in Essential Hypertension

Laurent, S., Katsahian, S., Fassot, C., Tropeano, A., Gautier, I., Laloux, B., & Boutouyrie, P. (2003) · Stroke · doi:10.1161/01.str.0000065428.03209.64 · Cited by 1,058 · see citing works

Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community.

Avolio, A. P., Chen, S. G., Wang, R. P., Zhang, C. L., Li, M., & OʼRourke, M. F. (1983) · Circulation · doi:10.1161/01.cir.68.1.50 · Cited by 965 · see citing works

Aortic Pulse Wave Velocity Predicts Cardiovascular Mortality in Subjects >70 Years of Age

Meaume, S., Benetos, A., Henry, O. F., Rudnichi, A., & Safar, M. E. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1201.100226 · Cited by 731 · see citing works

Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease

ARAYA, J., RODRIGO, R., VIDELA, L. A., THIELEMANN, L., ORELLANA, M., PETTINELLI, P., & PONIACHIK, J. (2004) · Clinical Science · doi:10.1042/cs20030326 · Cited by 700 · see citing works

Influences of age and gender on results of noninvasive brachial–ankle pulse wave velocity measurement—a survey of 12 517 subjects

Tomiyama, H., Yamashina, A., Arai, T., Hirose, K., Koji, Y., Chikamori, T., Hori, S., Yamamoto, Y., Doba, N., & Hinohara, S. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(02)00332-5 · Cited by 617 · see citing works

Non–Insulin-Dependent Diabetes Mellitus and Fasting Glucose and Insulin Concentrations Are Associated With Arterial Stiffness Indexes

Salomaa, V. V., Riley, W. A., Kark, J. D., Nardo, C. J., & Folsom, A. R. (1995) · Circulation · doi:10.1161/01.cir.91.5.1432 · Cited by 580 · see citing works

Nonalcoholic steatohepatitis: A study of 49 patients

Lee, R. G. (1989) · Human Pathology · doi:10.1016/0046-8177(89)90249-9 · Cited by 547 · see citing works

In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases

Seki, S., Kitada, T., Yamada, T., Sakaguchi, H., Nakatani, K., & Wakasa, K. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00073-9 · Cited by 523 · see citing works

Ratio of Serum Aspartate to Alanine Aminotransferase in Chronic Hepatitis Relationship to Cirrhosis

Williams, A. L. B., & Hoofnagle, J. H. (1988) · Gastroenterology · doi:10.1016/s0016-5085(88)80022-2 · Cited by 518 · see citing works

Increased Central Artery Stiffness in Impaired Glucose Metabolism and Type 2 Diabetes

Schram, M. T., Henry, R. M. A., van Dijk, R. A. J. M., Kostense, P. J., Dekker, J. M., Nijpels, G., Heine, R. J., Bouter, L. M., Westerhof, N., & Stehouwer, C. D. A. (2003) · Hypertension · doi:10.1161/01.hyp.0000111829.46090.92 · Cited by 439 · see citing works

Coronary risk prediction in adults (The Framingham Heart Study)

Wilson, P. W. F., Castelli, W. P., & Kannel, W. B. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)90165-2 · Cited by 381 · see citing works

Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension

Ferrier, K. E., Muhlmann, M. H., Baguet, J.-P., Cameron, J. D., Jennings, G., Dart, A. M., & Kingwell, B. A. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01717-5 · Cited by 316 · see citing works

Familial hypobetalipoproteinemia.

Linton, M., Farese, R., & Young, S. G. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39976-4 · Cited by 257 · see citing works

Carotid artery distensibility and distending pressure in hypertensive humans.

Laurent, S., Caviezel, B., Beck, L., Girerd, X. J., Billaud, E. M., Boutouyrie, P., Hoeks, A. P. G., & Safar, M. E. (1994) · Hypertension · doi:10.1161/01.hyp.23.6.878 · Cited by 253 · see citing works

Lipid disorders and mutations in the APOB gene

Whitfield, A. J., Barrett, P. H. R., van Bockxmeer, F. M., & Burnett, J. R. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.038026 · Cited by 243 · see citing works

Vascular stiffening and arterial complianceImplications for systolic blood pressure

Schiffrin, E. L. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.08.019 · Cited by 180 · see citing works

Unfavorable effect of smoking on the elastic properties of the human aorta

Stefanadis, C., Tsiamis, E., Vlachopoulos, C., Stratos, C., Toutouzas, K., Pitsavos, C., Marakas, S., Boudoulas, H., & Toutouzas, P. (1997) · Circulation · doi:10.1161/01.cir.95.1.31 · Cited by 177 · see citing works

Fatty infiltration of the liver: ultrasonographic and computed tomographic correlation.

Scatarige, J. C., Scott, W. W., Donovan, P. J., Siegelman, S. S., & Sanders, R. C. (1984) · Journal of Ultrasound in Medicine · doi:10.7863/jum.1984.3.1.9 · Cited by 162 · see citing works

CYP2E1: from ASH to NASH

Lieber, C. S. (2003) · Hepatology Research · doi:10.1016/j.hepres.2003.08.001 · Cited by 156 · see citing works

Fatty liver in familial hypobetalipoproteinemia

Tanoli, T. S. K., Yue, P., Yablonskiy, D. A., & Schonfeld, G. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300508-jlr200 · Cited by 154 · see citing works

Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis

Schonfeld, G., Patterson, B. W., Yablonskiy, D. A., Tanoli, T. S. K., Averna, M. R., Elias, N., Yue, P., & Ackerman, J. J. H. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200342-jlr200 · Cited by 143 · see citing works

Smoking and caffeine have a synergistic detrimental effect on aortic stiffness and wave reflections

Vlachopoulos, C., Kosmopoulou, F., Panagiotakos, D., Ioakeimidis, N., Alexopoulos, N., Pitsavos, C., & Stefanadis, C. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.049 · Cited by 135 · cited 4× · see citing works

Ratio of Serum Aspartate to Alanine Aminotransferase in Chronic Hepatitis

Williams, B. A., & Hoofnagle, J. H. (1988) · Cited by 133 · see citing works

Unfavorable effects of passive smoking on aortic function in men

Stefanadis, C., Vlachopoulos, C., Tsiamis, E., Diamantopoulos, L., Toutouzas, K., Giatrakos, N., Vaina, S., Tsekoura, D., & Toutouzas, P. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-6-199803150-00002 · Cited by 132 · cited 3× · see citing works

Diabetes mellitus, obesity, and hepatic steatosis.

Youssef, W. I., & McCullough, A. J. (2002) · PubMed · Cited by 127 · see citing works

Systolic Blood Pressure Revisited

Smulyan, H., & Safar, M. E. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00081-8 · Cited by 123 · see citing works

Nonalcoholic fatty liver disease.

Yu, A. S., & Keeffe, E. B. (2002) · PubMed · Cited by 110 · see citing works

The effect of cholesterol lowering on carotid and femoral artery wall stiffness and thickness in patients with familial hypercholesterolaemia

Smilde, Berkmortel, V. D., Wollersheim, Langen, V., Kastelein, & Stalenhoef (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00654.x · Cited by 105 · see citing works

Fatty liver in heterozygous hypobetalipoproteinemia caused by a novel truncated form of apolipoprotein B

Tarugi, P., Lonardo, A., Ballarini, G., Grisendi, A., Pulvirenti, M., Bagni, A., & Calandra, S. (1996) · Gastroenterology · doi:10.1016/s0016-5085(96)70082-3 · Cited by 102 · see citing works

Treatment of nonalcoholic fatty liver disease

Angulo, P. (2002) · Annals of Hepatology · doi:10.1016/s1665-2681(19)32187-8 · Cited by 99 · see citing works

A Novel Nontruncating APOB Gene Mutation, R463W, Causes Familial Hypobetalipoproteinemia

Burnett, J. R., Shan, J., Miskie, B. A., Whitfield, A. J., Yuan, J. Y., Tran, K. T., McKnight, C. J., Hegele, R. A., & Yao, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300235200 · Cited by 90 · see citing works

Cigar smoking has an acute detrimental effect on arterial stiffness

Vlachopoulos, C. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2003.12.014 · Cited by 76 · see citing works

Frequency of ApoB and ApoE Gene Mutations as Causes of Hypobetalipoproteinemia in the Framingham Offspring Population

Welty, F. K., Lahoz, C., Tucker, K. L., Ordovás, J. M., Wilson, P. W. F., & Schaefer, E. J. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.11.1745 · Cited by 71 · see citing works

Advances in the Understanding and Treatment of Nonalcoholic Fatty Liver Disease

Harrison, S. A., & Bisceglie, A. M. D. (2003) · Drugs · doi:10.2165/00003495-200363220-00001 · Cited by 69 · see citing works

A study of fatty liver disease and plasma lipoproteins in a kindred with familial hypobetalipoproteinemia due to a novel truncated form of apolipoprotein B (APO B-54.5)

Tarugi, P., Lonardo, A., Ballarini, G., Erspamer, L., Tondelli, E., Bertolini, S., & Calandra, S. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80270-6 · Cited by 55 · see citing works

High frequency of APOB gene mutations causing familial hypobetalipoproteinaemia in patients of Dutch and Spanish descent

Fouchier, S. W., Sankatsing, R. R., Peter, J., Castillo, S., Pocovi, M., Rodrigo Alonso, K., Kastelein, J. J. P., & Defesche, J. C. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.029454 · Cited by 47 · see citing works

Atherosclerosis measured by B-Mode ultrasonography: effect of statin therapy on disease progression

Kastelein, J. J. P., de Groot, E., & Sankatsing, R. R. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.02.009 · Cited by 45 · see citing works

Liver Dysfunction and Steatosis in Familial Hypobetalipoproteinemia

Whitfield, A. J., Barrett, P. H. R., Robertson, K., Havlat, M. F., BOCKXMEER, F. M. V., & Burnett, J. R. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.037978 · Cited by 38 · see citing works

Hepatic secretion of apoB-100 is impaired in hypobetalipoproteinemic mice with an apoB-38.9-specifying allele

Chen, Z., Fitzgerald, R. L., Li, G., Davidson, N. O., & Schonfeld, G. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300275-jlr200 · Cited by 29 · see citing works

Organ Loci of Catabolism of Short Truncations of ApoB

Zhu, X.-F., Noto, D., Seip, R. L., Shaish, A., & Schonfeld, G. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.6.1032 · Cited by 25 · see citing works

847-5 Systolic blood pressure measured serially from childhood to adulthood predicts arterial stiffness in young adults: The bogalusa heart study

Li, S., Chen, W., Srinivasan, S. R., & Berenson, G. S. (2004) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(04)92182-1 · Cited by 1 · see citing works

The safety of statins in clinical practice

Armitage, J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60716-8 · Cited by 833 · see citing works

Non-alcoholic fatty liver disease and increased risk of cardiovascular disease

Targher, G., & Arcaro, G. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.08.021 · Cited by 551 · see citing works

Lomitapide and Mipomersen

Rader, D. J., & Kastelein, J. J. P. (2014) · Circulation · doi:10.1161/circulationaha.113.001292 · Cited by 264 · see citing works

Non-alcoholic fatty liver disease and risk of cardiovascular disease

Lonardo, A., Sookoian, S. C., Pirola, C. J., & Targher, G. (2015) · Metabolism · doi:10.1016/j.metabol.2015.09.017 · Cited by 236 · see citing works

Randomized, Placebo-Controlled Trial of Mipomersen in Patients with Severe Hypercholesterolemia Receiving Maximally Tolerated Lipid-Lowering Therapy

McGowan, M. P., Tardif, J., Češka, R., Burgess, L. J., Soran, H., Gouni‐Berthold, I., Wagener, G., & Chasan-Taber, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049006 · Cited by 222 · see citing works

Pharmacological targeting of the atherogenic dyslipidemia complex: the next frontier in CVD prevention beyond lowering LDL cholesterol

Xiao, C., Dash, S., Morgantini, C., Hegele, R. A., & Lewis, G. F. (2016) · Diabetes · doi:10.2337/db16-0046 · Cited by 212 · see citing works

New Therapies Targeting apoB Metabolism for High-Risk Patients with Inherited Dyslipidaemias: What Can the Clinician Expect?

Sahebkar, A., & Watts, G. F. (2013) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-013-6479-4 · Cited by 176 · see citing works

Molecular diagnosis of hypobetalipoproteinemia: An ENID review

Tarugi, P., Averna, M. R., Leo, E. D., Cefalu, A. B., Noto, D., Magnolo, L., Cattin, L., Bertolini, S., & Calandra, S. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.05.003 · Cited by 172 · see citing works

Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia

Filippo, M. D., Moulin, P., Roy, P., Bouma, M. E., Collardeau‐Frachon, S., Chebel-Dumont, S., Peretti, N., Dumortier, J., Zoulim, F., Fontanges, T., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.05.023 · Cited by 147 · see citing works

Genetic determinants of hepatic steatosis in man

Hooper, A. J., Adams, L. A., & Burnett, J. R. (2011) · Journal of Lipid Research · doi:10.1194/jlr.r008896 · Cited by 142 · see citing works

Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology

Loria, P., Marchesini, G., Nascimbeni, F., Ballestri, S., Maurantonio, M., Carubbi, F., Ratziu, V., & Lonardo, A. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.10.030 · Cited by 135 · see citing works

Update on the molecular biology of dyslipidemias

Ramasamy, I. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.10.033 · Cited by 126 · see citing works

Hypobetalipoproteinemia

Tarugi, P., & Averna, M. R. (2011) · Advances in clinical chemistry · doi:10.1016/b978-0-12-387025-4.00004-2 · Cited by 125 · see citing works

Integrated Safety Assessment of 2′-O-Methoxyethyl Chimeric Antisense Oligonucleotides in NonHuman Primates and Healthy Human Volunteers

Crooke, S. T., Baker, B. F., Kwoh, T. J., Cheng, W., Schulz, D. J., Xia, S., Salgado, N. R., Bui, H., Hart, C. E., Burel, S. A., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.136 · Cited by 118 · see citing works

Pharmacological strategies for lowering LDL cholesterol: statins and beyond

Brautbar, A., & Ballantyne, C. M. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.2 · Cited by 114 · see citing works

Effect of apolipoprotein-B synthesis inhibition on liver triglyceride content in patients with familial hypercholesterolemia

Visser, M. E., Akdim, F., Tribble, D. L., Nederveen, A. J., Kwoh, T. J., Kastelein, J. J. P., Trip, M. D., & Stroes, E. S. G. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m002915 · Cited by 112 · see citing works

Diagnosis and management of secondary causes of steatohepatitis

Liebe, R., Esposito, I., Bock, H. H., Dahl, S. V., Stindt, J., Baumann, U., Luedde, T., & Keitel, V. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.01.045 · Cited by 108 · see citing works

Antisense oligonucleotides for the treatment of dyslipidaemia

Visser, M. E., Witztum, J. L., Stroes, E. S. G., & Kastelein, J. J. P. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs084 · Cited by 102 · see citing works

Monogenic Hypocholesterolaemic Lipid Disorders and Apolipoprotein B Metabolism

Hooper, A. J., BOCKXMEER, F. M. V., & Burnett, J. R. (2005) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360500295113 · Cited by 99 · see citing works

Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis

Minicocci, I., Santini, S., Cantisani, V., Stitziel, N., Kathiresan, S., Arroyo, J. A., Martí, G., Pisciotta, L., Noto, D., Cefalù, A. B., et al. (2013) · Journal of Lipid Research · doi:10.1194/jlr.p039875 · Cited by 97 · see citing works

A Locked Nucleic Acid Oligonucleotide Targeting MicroRNA 122 Is Well-Tolerated in Cynomolgus Monkeys

Hildebrandt-Eriksen, E. S., Aarup, V., Persson, R., Hansen, H. F., Munk, M. E., & Ørum, H. (2012) · Nucleic Acid Therapeutics · doi:10.1089/nat.2011.0332 · Cited by 97 · see citing works

Evidence-based goals in LDL-C reduction

Soran, H., Dent, R., & Durrington, P. (2017) · Clinical Research in Cardiology · doi:10.1007/s00392-016-1069-7 · Cited by 92 · see citing works

Contemporary Aspects of the Biology and Therapeutic Regulation of the Microsomal Triglyceride Transfer Protein

Hooper, A. J., Burnett, J. R., & Watts, G. F. (2014) · Circulation Research · doi:10.1161/circresaha.116.304637 · Cited by 85 · see citing works

Lipoprotein metabolism in nonalcoholic fatty liver disease

Jiang, Z. G., Simon, K. A., & Zemin, Y. (2013) · Journal of Biomedical Research · doi:10.7555/jbr.27.20120077 · Cited by 83 · see citing works

Prevalence of ANGPTL3 and APOB Gene Mutations in Subjects With Combined Hypolipidemia

Noto, D., Cefalu, A. B., Valenti, V., Fayer, F., Pinotti, E., Ditta, M., Spina, R., Vigna, G. B., Yue, P., Kathiresan, S., et al. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.238766 · Cited by 82 · see citing works

A Novel APOB Mutation Identified by Exome Sequencing Cosegregates With Steatosis, Liver Cancer, and Hypocholesterolemia

Cefalu, A. B., Pirruccello, J. P., Noto, D., Gabriel, S., Valenti, V., Gupta, N., Spina, R., Tarugi, P., Kathiresan, S., & Averna, M. R. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.301101 · Cited by 83 · see citing works

Rare Protein-Truncating Variants in APOB , Lower Low-Density Lipoprotein Cholesterol, and Protection Against Coronary Heart Disease

Peloso, G. M., Nomura, A., Khera, A. V., Chaffin, M. D., Won, H., Ardissino, D., Danesh, J., Schunkert, H., Wilson, J. G., Samani, N. J., et al. (2019) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.118.002376 · Cited by 71 · see citing works

Missense Mutations in APOB within the βα1 Domain of Human APOB-100 Result in Impaired Secretion of ApoB and ApoB-containing Lipoproteins in Familial Hypobetalipoproteinemia

Burnett, J. R., Zhong, S., Jiang, Z. G., Hooper, A. J., Fisher, E. A., McLeod, R. S., Zhao, Y., Barrett, P. H. R., Hegele, R. A., BOCKXMEER, F. M. V., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702442200 · Cited by 71 · see citing works

How low is safe? The frontier of very low (<30 mg/dL) LDL cholesterol

Karagiannis, A. D., Mehta, A., Dhindsa, D. S., Virani, S. S., Orringer, C. E., Blumenthal, R. S., Stone, N. J., & Sperling, L. S. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa1080 · Cited by 70 · see citing works

Identification of a novel mutation in the ANGPTL3 gene in two families diagnosed of familial hypobetalipoproteinemia without APOB mutation

Martín-Campos, J. M., Roig, R., Mayoral, C., Martinez, S., Martí, G., Arroyo, J. A., Julve, J., & Blanco‐Vaca, F. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.11.020 · Cited by 65 · see citing works

Noninvasive Differentiation between Hepatic Steatosis and Steatohepatitis with MR Imaging Enhanced with USPIOs in Patients with Nonalcoholic Fatty Liver Disease: A Proof-of-Concept Study

Smits, L. P., Coolen, B. F., Panno, M. D., Runge, J. H., Nijhof, W. H., Verheij, J., Nieuwdorp, M., Stoker, J., Beuers, U. H., Nederveen, A. J., et al. (2015) · Radiology · doi:10.1148/radiol.2015150952 · Cited by 60 · see citing works

Update on Primary Hypobetalipoproteinemia

Hooper, A. J., & Burnett, J. R. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0423-3 · Cited by 58 · see citing works

Anti-PCSK9 therapies for the treatment of hypercholesterolemia

Hooper, A. J., & Burnett, J. R. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.748743 · Cited by 46 · see citing works

Clinical and biochemical characteristics of individuals with low cholesterol syndromes: A comparison between familial hypobetalipoproteinemia and familial combined hypolipidemia

Costanzo, A. D., Leo, E. D., Noto, D., Cefalu, A. B., Minicocci, I., Polito, L., D’Erasmo, L., Cantisani, V., Spina, R., Tarugi, P., et al. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.06.013 · Cited by 46 · see citing works

Familial Hypercholesterolemia: Present and Future Management

Sjouke, B., Kusters, D. M., Kastelein, J. J. P., & Hovingh, G. K. (2011) · Current Cardiology Reports · doi:10.1007/s11886-011-0219-9 · Cited by 44 · see citing works

Apolipoprotein B synthesis inhibition: results from clinical trials

Visser, M. E., Kastelein, J. J. P., & Stroes, E. S. G. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32833af4c1 · Cited by 44 · see citing works

ApoB100 and Atherosclerosis: What’s New in the 21st Century?

Kounatidis, D. C., Vallianou, N. G., Poulaki, A., Evangelopoulos, A. A., Panagopoulos, F., Stratigou, T., Geladari, E. V., Karampela, Ι., & Dalamaga, Μ. (2024) · Metabolites · doi:10.3390/metabo14020123 · Cited by 45 · see citing works

Safety and Effect of Very Low Levels of Low-Density Lipoprotein Cholesterol on Cardiovascular Events

LaRosa, J. C., Pedersen, T. R., Somaratne, R. M., & Wasserman, S. M. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.12.052 · Cited by 41 · see citing works

The influence of obesity and metabolic risk variables on brachial-ankle pulse wave velocity in healthy adolescents

Miyai, N., Arita, M., Miyashita, K., Morioka, I., & Takeda, S. (2008) · Journal of Human Hypertension · doi:10.1038/jhh.2008.143 · Cited by 41 · see citing works

Cryptogenic cirrhosis in a patient with familial hypocholesterolemia due to a new truncated form of apolipoprotein B

Bonnefont‐Rousselot, D., Condat, B., Sassolas, A., Chebel, S., Bittar, R., Federspiel, M.-C., Cazals-Hatem, D. L., & Bruckert, É. (2008) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3282ffd9f8 · Cited by 40 · see citing works

Genetics of Dyslipidemia

García-Giustiniani, D. A., & Stein, R. (2016) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20160074 · Cited by 39 · see citing works

Lipoprotein apheresis and new therapies for severe familial hypercholesterolemia in adults and children

Page, M. M., Bell, D. A., Hooper, A. J., Watts, G. F., & Burnett, J. R. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.10.004 · Cited by 34 · see citing works

Gene-based therapy in lipid management: the winding road from promise to practice

Tromp, T. R., Stroes, E. S. G., & Hovingh, G. K. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1757070 · Cited by 33 · see citing works

Primary hypocholesterolemia is associated with an increased risk of hepatic complications in the general population

Wargny, M., Goronflot, T., Rimbert, A., Boursier, J., Kab, S., Henny, J., Lainé, A., Leux, C., Smati, S., Hadjadj, S., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.01.030 · Cited by 28 · see citing works

Clinical Implications of Lipid Genetics for Cardiovascular Disease

Strong, A., & Rader, D. J. (2010) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-010-0131-7 · Cited by 28 · see citing works

Development of Apolipoprotein B Antisense Molecules as a Therapy for Hyperlipidemia

Thomas, T. A., & Ginsberg, H. N. (2009) · Current Atherosclerosis Reports · doi:10.1007/s11883-009-0078-7 · Cited by 27 · see citing works

Current and Future Pharmacologic Options for the Management of Patients Unable to Achieve Low-Density Lipoprotein-Cholesterol Goals with Statins

Harchaoui, K. E., Akdim, F., Stroes, E. S. G., Trip, M. D., & Kastelein, J. J. P. (2008) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200808040-00003 · Cited by 27 · see citing works

Sterol and lipid analyses identifies hypolipidemia and apolipoprotein disorders in autism associated with adaptive functioning deficits

Tierney, E., Remaley, A. T., Thurm, A., Jager, L. R., Wassif, C. A., Kratz, L. E., Bailey-Wilson, J. E., Bukelis, I., Sarphare, G., Jung, E. S., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01580-8 · Cited by 26 · see citing works

Efficacy and safety of PCSK9 monoclonal antibodies

Iqbal, Z., Dhage, S. S., Mohamad, J. B., Abdel-Razik, A. E. S., Donn, R. P., Malik, R. A., Ho, J. H., Liu, Y., Adam, S., Isa, B., et al. (2019) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2019.1681395 · Cited by 24 · see citing works

New Clinical Perspectives of Hypolipidemic Drug Therapy in Severe Hypercholesterolemia

Stefanutti, C., Morozzi, C., & Giacomo, S. D. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712803341485 · Cited by 23 · see citing works

Association between familial hypobetalipoproteinemia and the risk of diabetes. Is this the other side of the cholesterol–diabetes connection? A systematic review of literature

Noto, D., Arca, M., Tarugi, P., Cefalu, A. B., Barbagallo, C. M., & Averna, M. R. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0931-4 · Cited by 22 · see citing works

The strengths and limitations of the ApoB/ApoA-I ratio to predict the risk of vascular disease: a hegelian analysis

Sniderman, A. D., & Kiss, R. S. (2007) · Current Atherosclerosis Reports · doi:10.1007/s11883-007-0031-6 · Cited by 22 · see citing works

APOB-Related Familial Hypobetalipoproteinemia

Burnett, J. R., Hooper, A. J., & Hegele, R. A. (2021) · Europe PMC (PubMed Central) · Cited by 21 · see citing works

Extremely low levels of low-density lipoprotein potentially suggestive of familial hypobetalipoproteinemia: A separate phenotype of NAFLD?

Mouzaki, M., Shah, A. D., Arce‐Clachar, A. C., Hardy, J., Bramlage, K., & Xanthakos, S. A. (2019) · Journal of clinical lipidology · doi:10.1016/j.jacl.2019.02.002 · Cited by 21 · see citing works

Vitamin E and oxidative stress in abetalipoproteinemia and familial hypobetalipoproteinemia

Burnett, J. R., & Hooper, A. J. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.044 · Cited by 21 · see citing works

Homozygous familial hypobetalipoproteinemia: Two novel mutations in the splicing sites of apolipoprotein B gene and review of the literature

Cefalu, A. B., Norata, G. D., Ghiglioni, D. G., Noto, D., Uboldi, P., Garlaschelli, K., Baragetti, A., Spina, R., Valenti, V., Pederiva, C., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.014 · Cited by 20 · see citing works

Is mipomersen ready for clinical implementation? A transatlantic dilemma

Sjouke, B., Balak, D., Beuers, U. H., Ratziu, V., & Stroes, E. S. G. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328362dfd9 · Cited by 20 · see citing works

Apolipoprotein B gene mutations and fatty liver in Japanese hypobetalipoproteinemia

Katsuda, S., Kawashiri, M., Inazu, A., Tada, H., Tsuchida, M., Kaneko, Y., Nozue, T., Nohara, A., Okada, T., Kobayashi, J., et al. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.09.021 · Cited by 19 · see citing works

Low cholesterol states: clinical implications and management

Gill, P. K., & Hegele, R. A. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2204932 · Cited by 19 · see citing works

Low LDL cholesterol—Friend or foe?

Hartz, J. C., Hegele, R. A., & Wilson, D. P. (2019) · Journal of clinical lipidology · doi:10.1016/j.jacl.2019.05.006 · Cited by 18 · see citing works

Low LDL-C levels are associated with risk of mortality in a Chinese cohort study

Lu, J., Wu, M., Yang, Z., Zhu, Y., Li, D., Yu, Z., Shen, P., Tang, M., Jin, M., Lin, H., et al. (2021) · Endocrine · doi:10.1007/s12020-021-02746-6 · Cited by 17 · see citing works

Update on the diagnosis, treatment and management of rare genetic lipid disorders

Ng, D., Burnett, J. R., Bell, D. A., Hegele, R. A., & Hooper, A. J. (2018) · Pathology · doi:10.1016/j.pathol.2018.11.005 · Cited by 17 · see citing works

New Treatment Targets and Innovative Lipid-Lowering Therapies in Very-High-Risk Patients with Cardiovascular Disease

Burger, A. L., Pogran, E., Muthspiel, M., Kaufmann, C. C., Jäger, B., & Huber, K. (2022) · Biomedicines · doi:10.3390/biomedicines10050970 · Cited by 16 · see citing works

Genetics of Lipid Traits and Relationship to Coronary Artery Disease

Keenan, T. E., & Rader, D. J. (2013) · Current Cardiology Reports · doi:10.1007/s11886-013-0396-9 · Cited by 16 · see citing works

Altered lipid metabolism and the development of metabolic-associated fatty liver disease

Foster, C., Gagnon, C. A., & Ashraf, A. P. (2024) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000933 · Cited by 19 · see citing works

Familial Defective Apolipoprotein B and Familial Hypobetalipoproteinemia in One Family: Two Neutralizing Mutations

van der Graaf, A., Fouchier, S. W., Vissers, M. N., Defesche, J. C., Wiegman, A., Sankatsing, R. R., Hutten, B. A., Trip, M. D., & Kastelein, J. J. P. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-9-200805060-00022 · Cited by 15 · see citing works

Managing recalcitrant hypercholesterolemia in patients on current best standard of care: efficacy and safety of novel pharmacotherapies

Sahebkar, A., & Watts, G. F. (2014) · Clinical Lipidology · doi:10.2217/clp.14.14 · Cited by 13 · see citing works

Angiopoietin-like 3 regulates hepatocyte proliferation and lipid metabolism in zebrafish

Lee, S.-H., So, J., Kim, H.-T., Choi, J., Lee, M., Choi, S., Kim, C., & Kim, J. M. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.03.099 · Cited by 13 · see citing works

Therapeutic potential of antisense oligonucleotides for the management of dyslipidemia

Crooke, R. M., & Graham, M. J. (2011) · Clinical Lipidology · doi:10.2217/clp.11.59 · Cited by 11 · see citing works

Non-alcoholic steatohepatitis-related cirrhosis in a patient with APOB L343V familial hypobetalipoproteinaemia

Heeks, L. V., Hooper, A. J., Adams, L. A., Robbins, P. A., Barrett, P. H. R., BOCKXMEER, F. M. V., & Burnett, J. R. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.03.004 · Cited by 12 · see citing works

LDL-C-Lowering therapy: Current and future therapeutic targets

Visser, M. E., Jakulj, L., Kastelein, J. J. P., & Stroes, E. S. G. (2008) · Current Cardiology Reports · doi:10.1007/s11886-008-0080-7 · Cited by 12 · see citing works

Age-Specific Nomogram of Brachial-Ankle Pulse Wave Velocity in Japanese Adolescents

Miyai, N., Utsumi, M., Gowa, Y., Igarashi, Y., Miyashita, K., Takeda, S., & Arita, M. (2012) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2012.690473 · Cited by 11 · see citing works

Discordance between apolipoprotein B or non-HDL-cholesterol and LDL-cholesterol in middle-aged and elderly Chinese patients predicts arterial stiffness

Qu, G., Zhang, Z., & Zhu, H. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01509-6 · Cited by 11 · see citing works

Familial hypobetalipoproteinemia: Analysis of three Spanish cases with two new mutations in the APOB gene

Martín-Morales, R., García-Díaz, J. D. D., Tarugi, P., González‐Santos, P., Saavedra-Vallejo, P., Magnolo, L., Mesa-Latorre, J. M., Leo, E. D., & Valdivielso, P. (2013) · Gene · doi:10.1016/j.gene.2013.08.049 · Cited by 10 · see citing works

Does inhibition of apolipoprotein B synthesis produce foie gras?

Feingold, K. R. (2009) · Journal of Lipid Research · doi:10.1194/jlr.e005140 · Cited by 10 · see citing works

Antisense technology to lower LDL cholesterol

Neely, R. D. G., & Bassendine, M. F. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60364-9 · Cited by 10 · see citing works

Do diabetes and obesity promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia?

Ballestri, S., Lonardo, A., Losi, L., Pellegrini, E., Bertolotti, M., & Loria, P. (2008) · Internal and Emergency Medicine · doi:10.1007/s11739-008-0178-3 · Cited by 9 · see citing works

Prevalence of Liver Steatosis and Fibrosis in Adults With Primary Hypobetaliproteinemia: Results From the HYPOCHOL Study

Smati, S., Wargny, M., Boursier, J., Moulin, P., Filippo, M. D., & Cariou, B. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.06.031 · Cited by 8 · see citing works

Antisense oligonucleotides in the treatment of lipid disorders: pitfalls and promises.

Besseling, J., Hovingh, G. K., & Stroes, E. S. G. (2013) · PubMed · Cited by 8 · see citing works

Drug targets beyond HMG-CoA reductase: Why venture beyond the statins?

Gelissen, I. C., & Brown, A. J. (2011) · Frontiers in Biology · doi:10.1007/s11515-011-1130-x · Cited by 8 · see citing works

Targeting ApoB as a therapeutic approach for the treatment of dyslipidemia: the potential role of mipomersen

Thomas, T. A., & Ginsberg, H. N. (2010) · Clinical Lipidology · doi:10.2217/clp.10.47 · Cited by 7 · see citing works

Apolipoprotein‐B

Williams, K. J., & Fisher, E. A. A. (2015) · Atherosclerosis · doi:10.1002/9781118828533.ch24 · Cited by 5 · see citing works

Novel Prognostic Indicators to reflect the grade of liver fibrosis in hepatic patients

El-Gazar, M. M. A., Fahmi, A. E., mohamed, A., & Elhakim, H. A. (2021) · Egyptian Journal of Chemistry · doi:10.21608/ejchem.2021.104682.4837 · Cited by 4 · see citing works

Hipobetalipoproteinemia familiar secundaria a mutación en el gen de la apolipoproteína B

Blanco-Rodríguez, M., Muñoz-Calvo, M. A., Martos‐Moreno, G. Á., Abad, E., & Argente-Oliver, J. (2007) · Anales de Pediatría · doi:10.1157/13102518 · Cited by 3 · see citing works

Rare primary dyslipidaemias associated with low LDL and HDL cholesterol values in Portugal

Alves, A. C., Miranda, B., Moldovan, O., Santo, R. E., Silva, R. G., Cardoso, S. S., Diogo, L. M., Seidi, M., Sequeira, S., & Bourbon, M. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2022.1088040 · Cited by 3 · see citing works

Genetics of familial hypobetalipoproteinemia

Tarugi, P., & Averna, M. R. (2007) · Future Lipidology · doi:10.2217/17460875.2.6.615 · Cited by 2 · see citing works

Health Outcomes Associated with Hypolipidemia: a Scoping Review

Hong, S., Choi, D.-J., & Jeong, J.-C. (2025) · The Journal of Internal Korean Medicine · doi:10.22246/jikm.2025.46.1.61 · Cited by 1 · see citing works

DYSLIPIDEMIAS

Murphy, M. S., & O’Brien, T. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3291-5.50027-5 · Cited by 1 · see citing works

MOLECULAR CHARACTERIZATION AND SPECTRUM OF MUTATIONS ASSOCIATED WITH AUTOSOMAL DOMINANT HYPERCHOLESTEROLEMIA

D’Agostino, M. N. (2014)

Emerging Therapeutic Approaches for Dyslipidemias Associated with High LDL and Low HDL

Schwarz, M., & Kim, J. B. (2011) · Wiley eBooks · doi:10.1002/9780470910016.ch8

Exome sequencing identifies novel ApoB loss-of-function mutations causing hypobetalipoproteinemia in type 1 diabetes

Gao, F., Luo, H., Fu, Z., Zhang, C., & Zhang, R. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0687-7

Conséquences métaboliques des malabsorptions lipidiques : apports de l’étude des hypocholestérolémies familiales

Peretti, N. (2012) · Oléagineux Corps gras Lipides · doi:10.1051/ocl.2012.0463

Novel Mutation in the Apob Gene (Apo B-15.56): A Case Report

Bove, M., Carnevali, L., Cicero, A. F. G., Tarugi, P., & Gaddi, A. V. (2010) · Balkan Journal of Medical Genetics · doi:10.2478/v10034-010-0029-1

Ailesel hipobetalipoproteinemiye bağli non-alkolik steatohepatitli hastalarda ursodeoksikolik asit tedavisi

Çıçek, B., Köksal, A. Ş., Oğuz, D., Erden, E., Parlak, E., & Şahın, B. (2005) · Akademik Gastroenteroloji Dergisi · doi:10.17941/agd.40942

Familial Low-Cholesterol Syndromes or Hypobetalipoproteinemias

Noto, D., Tarugi, P., & Averna, M. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.98702-6

Formes rares de dyslipidémies génétiques

Luc, G. (2010) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(10)51264-2

Hepatosteatosis may reveal heterozygous familial hypobetalipoproteinemia

Mazokopakis, E. E., Karefilaki, S., Syros, P. K., & Lioudaki, E. (2013)

Current World Literature

(2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000244230.06529.0f

Primär genetische Dyslipoproteinämien und Atheroskleroserisiko

Schwab, K. O., & Doerfer, J. (2022) · Springer eBooks · doi:10.1007/978-3-662-63320-5_3

Primer hipolipoproteinemili hastalarda monosit/yüksek yoğunluklu lipoprotein kolesterol oranı

Tekin, M. Ş. (2022) · DergiPark (Istanbul University) · doi:10.47582/jompac.1162205

Abstract 18296: Investigation of Hepatic and Vascular Changes Associated with Familial Combined Hypolipidemia

Arca, M., Minicocci, I., Cantisani, V., Poggiogalle, E., Favari, E., Zimetti, F., Montali, A., Labbadia, G., Pigna, G., Maranghi, M., et al. (2012) · Circulation · doi:10.1161/circ.126.suppl_21.a18296

Non-Alcoholic Steatohepatitis in APOB C.2999+1G > A Familial Hypobetalipoproteinaemia

Ng, D., Hooper, A. J., Bell, D. A., Wallace, M., Adams, L. A., & Burnett, J. R. (2018) · Heart Lung and Circulation · doi:10.1016/j.hlc.2018.06.719

A case of suspicious fatty liver and seven non-fatty liver cases with hypobetalipoproteinemia, experienced in a community cohort

Sonoda, A., & Shimada, T. (2023) · Open Journal of Clinical and Medical Case Reports · doi:10.52768/2379-1039/2105

Familial hypobetalipoproteinemia and liver steatosis.

Allora, C., Molini, V., BUGIANESI, E., I., R., Bonardi, R., Bondone, C., & Guardamagna, O. (2002) · Institutional Research Information System University of Turin (University of Turin)

Familial hypobetalipoproteinemia [Ailesel hipobetalipoproteinemi]

(2007) · Dspace Repository (Marmara Üniversitesi)